Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Faster, Cleaner, Better.

First Trust/Aberdeen Emerging Opportunity Fund (FEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Comparison for [[ item.sessionDateDisplayLong ]]

Results

Want to compare other data? Select Fields

Symbol	FEO
Company	First Trust/Aberdeen Emerging Opportunity Fund
Price Information
Exchange	NYSE
Open	9.56
High	9.59
Low	9.55
Latest	9.58
Change	+0.03
% Change	+0.31%
Volume	150,200
20-Day Average Volume	53,470
Previous Close	9.55
Industry	N/A
Has Options	No
Technicals
20-Day Moving Average	9.35
20-Day Raw Stochastic	98.61%
20-Day Relative Strength	70.66
Weighted Alpha	-23.67
Today's Opinion	56% Buy
Previous Opinion	56% Buy
Last Month's Opinion	40% Sell
Performance
5-Days
%Chg	+1.27% since 11/23/22
Low	9.46 on 11/25/22
High	9.59 on 12/01/22
1-Month
%Chg	+7.88% since 11/01/22
Low	8.87 on 11/03/22
High	9.59 on 12/01/22
3-Month
%Chg	+8.25% since 09/01/22
Low	8.35 on 10/25/22
High	9.70 on 09/21/22
6-Month
%Chg	+2.79% since 06/01/22
Low	8.35 on 10/25/22
High	9.70 on 09/21/22
Key Statistics
Market Capitalization, $K	N/A
Shares Outstanding, K	N/A
Annual Sales	-3,939,883
Annual Net Income	-4,188,763
Last Quarter Sales	N/A
Last Quarter Net Income	N/A
60-Month Beta	N/A
Per-Share Information
Most Recent Earnings	N/A
Latest Earnings Date	N/A
Most Recent Dividend	N/A
Next Ex-Dividends Date	09/22/22
Ratios
Price/Earnings ttm	N/A